FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4303984861> ?p ?o ?g. }

• W4303984861 endingPage "A866" @default.
• W4303984861 startingPage "A865" @default.
• W4303984861 abstract "SESSION TITLE: Studies on COVID-19 Infections Abstract PostersSESSION TYPE: Original Investigation PostersPRESENTED ON: 10/18/2022 01:30 pm - 02:30 pmPURPOSE: Latent Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are commonly reactivated in critically ill patients with severe infections. This study aimed to evaluate the proportion of reactivation of EBV and CMV and its impact on length of stay, need for ventilation, and Ichikado CT scores in patients with coronavirus disease 2019 (COVID-19).METHODS: A retrospective study was conducted comprising adult patients admitted to our hospital with COVID-19 infection from June 2021 to September 2021. Patients were divided into groups: virus-free, EBV-only, CMV-only, and EBV and CMV detected. Primary outcomes were length of stay, need for ventilation, and Ichikado CT score. Descriptive statistics, one-way ANOVA, Games-Howell, and Kruskal-Wallis tests were used.RESULTS: 189 patients were included with a median age of 51 years [41 – 66], 80 (42.3%) were female and 109 (57.7%) were male. CD4(+) counts were lower in all viral reactivation groups. EBV-only (157 cell/µl [93 – 279.2] ), CMV-only (82.5 cell/µl [65.5 – 323.7] ), both viruses (62.5 cell/µl [47.5 – 135.5]) and virus-free (221 cell/µl [117 – 318]), (H(3) = 12.029, p = < 0.01). A significant increase in the Ichikado CT score was seen in the viral reactivation groups. EBV 186.5 [43.6], CMV 177.5 [41.6], both-viruses group 204 [50.3] vs. virus-free 161 [45.8],( H(3) = 15.770, p = < 0.01). There was an increase in days of hospitalization when comparing the virus-free and the viral reactivation groups. EBV (9 days [5.5-15.5]), CMV (17 days [3-33]), both viruses (23 days [8-31]) vs. virus-free (5 days [3.5-9]), (H(3) = 15.487, p = < 0.01). Regarding the need for assisted ventilation, there was no difference between groups. 7 (9.1%) patients in the virus-free group, 29 (29.9%) patients in the EBV group, 2 (33.3%) patients in the CMV group, and 2 (22.2%) patients in the both-viruses group needed mechanical ventilation (X2 (3, N=189) = 11.699, p= 0.08). Additionally, a statistically significant decrease in albumin levels on admission was found in the EBV-only patients compared to the virus-free group, (3.4 g/dL [0.44] vs 3.75 g/dL [0.46], F(3,185) = 5.483, p = < 0.01).CONCLUSIONS: Viral reactivation is associated with lower CD4(+) count, an increase in length of stay, and higher Ichikado CT scores.CLINICAL IMPLICATIONS: EVB and CMV reactivation is associated with low CD4(+) counts and longer hospital stay.DISCLOSURES: No relevant relationships by David AkinwaleNo relevant relationships by Angelica AlmaguerNo relevant relationships by Sushen BhallaNo relevant relationships by Ailine Canete CruzNo relevant relationships by Ndiya EmeabaSpeaker/Speaker's relationship with johnson and johnson Please note: approx year 2000 Added 03/31/2022 by Joseph Gathe, value=Honorariaclinical research relationship with gilead Please note: since 1990 Added 03/31/2022 by Joseph Gathe, value=Grant/Researchclinical research relationship with ansun Please note: 2020 Added 03/31/2022 by Joseph Gathe, value=Grant/Research Supportclinical research relationship with regeneron Please note: 2020 Added 03/31/2022 by Joseph Gathe, value=Grant/Research SupportNo relevant relationships by Jesus Salvador Gonzalez LopezNo relevant relationships by Najia HussainiNo relevant relationships by Claudia RamirezNo relevant relationships by Salim SuraniNo relevant relationships by Daryelle VaronNo relevant relationships by Joseph VaronNo relevant relationships by Mohamed Ziad SESSION TITLE: Studies on COVID-19 Infections Abstract Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: 10/18/2022 01:30 pm - 02:30 pm PURPOSE: Latent Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are commonly reactivated in critically ill patients with severe infections. This study aimed to evaluate the proportion of reactivation of EBV and CMV and its impact on length of stay, need for ventilation, and Ichikado CT scores in patients with coronavirus disease 2019 (COVID-19). METHODS: A retrospective study was conducted comprising adult patients admitted to our hospital with COVID-19 infection from June 2021 to September 2021. Patients were divided into groups: virus-free, EBV-only, CMV-only, and EBV and CMV detected. Primary outcomes were length of stay, need for ventilation, and Ichikado CT score. Descriptive statistics, one-way ANOVA, Games-Howell, and Kruskal-Wallis tests were used. RESULTS: 189 patients were included with a median age of 51 years [41 – 66], 80 (42.3%) were female and 109 (57.7%) were male. CD4(+) counts were lower in all viral reactivation groups. EBV-only (157 cell/µl [93 – 279.2] ), CMV-only (82.5 cell/µl [65.5 – 323.7] ), both viruses (62.5 cell/µl [47.5 – 135.5]) and virus-free (221 cell/µl [117 – 318]), (H(3) = 12.029, p = < 0.01). A significant increase in the Ichikado CT score was seen in the viral reactivation groups. EBV 186.5 [43.6], CMV 177.5 [41.6], both-viruses group 204 [50.3] vs. virus-free 161 [45.8],( H(3) = 15.770, p = < 0.01). There was an increase in days of hospitalization when comparing the virus-free and the viral reactivation groups. EBV (9 days [5.5-15.5]), CMV (17 days [3-33]), both viruses (23 days [8-31]) vs. virus-free (5 days [3.5-9]), (H(3) = 15.487, p = < 0.01). Regarding the need for assisted ventilation, there was no difference between groups. 7 (9.1%) patients in the virus-free group, 29 (29.9%) patients in the EBV group, 2 (33.3%) patients in the CMV group, and 2 (22.2%) patients in the both-viruses group needed mechanical ventilation (X2 (3, N=189) = 11.699, p= 0.08). Additionally, a statistically significant decrease in albumin levels on admission was found in the EBV-only patients compared to the virus-free group, (3.4 g/dL [0.44] vs 3.75 g/dL [0.46], F(3,185) = 5.483, p = < 0.01). CONCLUSIONS: Viral reactivation is associated with lower CD4(+) count, an increase in length of stay, and higher Ichikado CT scores. CLINICAL IMPLICATIONS: EVB and CMV reactivation is associated with low CD4(+) counts and longer hospital stay. DISCLOSURES: No relevant relationships by David Akinwale No relevant relationships by Angelica Almaguer No relevant relationships by Sushen Bhalla No relevant relationships by Ailine Canete Cruz No relevant relationships by Ndiya Emeaba Speaker/Speaker's relationship with johnson and johnson Please note: approx year 2000 Added 03/31/2022 by Joseph Gathe, value=Honoraria clinical research relationship with gilead Please note: since 1990 Added 03/31/2022 by Joseph Gathe, value=Grant/Research clinical research relationship with ansun Please note: 2020 Added 03/31/2022 by Joseph Gathe, value=Grant/Research Support clinical research relationship with regeneron Please note: 2020 Added 03/31/2022 by Joseph Gathe, value=Grant/Research Support No relevant relationships by Jesus Salvador Gonzalez Lopez No relevant relationships by Najia Hussaini No relevant relationships by Claudia Ramirez No relevant relationships by Salim Surani No relevant relationships by Daryelle Varon No relevant relationships by Joseph Varon No relevant relationships by Mohamed Ziad" @default.
• W4303984861 created "2022-10-10" @default.
• W4303984861 creator A5013177227 @default.
• W4303984861 creator A5018019216 @default.
• W4303984861 creator A5031945357 @default.
• W4303984861 creator A5041457307 @default.
• W4303984861 creator A5043183455 @default.
• W4303984861 creator A5044455386 @default.
• W4303984861 creator A5048922067 @default.
• W4303984861 creator A5048990766 @default.
• W4303984861 creator A5050066926 @default.
• W4303984861 creator A5061652086 @default.
• W4303984861 creator A5070048354 @default.
• W4303984861 creator A5077281152 @default.
• W4303984861 creator A5088437019 @default.
• W4303984861 date "2022-10-01" @default.
• W4303984861 modified "2023-09-25" @default.
• W4303984861 title "REACTIVATION OF EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH COVID-19" @default.
• W4303984861 doi "https://doi.org/10.1016/j.chest.2022.08.684" @default.
• W4303984861 hasPublicationYear "2022" @default.
• W4303984861 type Work @default.
• W4303984861 citedByCount "0" @default.
• W4303984861 crossrefType "journal-article" @default.
• W4303984861 hasAuthorship W4303984861A5013177227 @default.
• W4303984861 hasAuthorship W4303984861A5018019216 @default.
• W4303984861 hasAuthorship W4303984861A5031945357 @default.
• W4303984861 hasAuthorship W4303984861A5041457307 @default.
• W4303984861 hasAuthorship W4303984861A5043183455 @default.
• W4303984861 hasAuthorship W4303984861A5044455386 @default.
• W4303984861 hasAuthorship W4303984861A5048922067 @default.
• W4303984861 hasAuthorship W4303984861A5048990766 @default.
• W4303984861 hasAuthorship W4303984861A5050066926 @default.
• W4303984861 hasAuthorship W4303984861A5061652086 @default.
• W4303984861 hasAuthorship W4303984861A5070048354 @default.
• W4303984861 hasAuthorship W4303984861A5077281152 @default.
• W4303984861 hasAuthorship W4303984861A5088437019 @default.
• W4303984861 hasBestOaLocation W43039848612 @default.
• W4303984861 hasConcept C116675565 @default.
• W4303984861 hasConcept C142724271 @default.
• W4303984861 hasConcept C159047783 @default.
• W4303984861 hasConcept C203014093 @default.
• W4303984861 hasConcept C2522874641 @default.
• W4303984861 hasConcept C2776409557 @default.
• W4303984861 hasConcept C2777732132 @default.
• W4303984861 hasConcept C2778137277 @default.
• W4303984861 hasConcept C2779134260 @default.
• W4303984861 hasConcept C2779820661 @default.
• W4303984861 hasConcept C2780494569 @default.
• W4303984861 hasConcept C2780727368 @default.
• W4303984861 hasConcept C2781375147 @default.
• W4303984861 hasConcept C3006700255 @default.
• W4303984861 hasConcept C3007834351 @default.
• W4303984861 hasConcept C3008058167 @default.
• W4303984861 hasConcept C3019738921 @default.
• W4303984861 hasConcept C524204448 @default.
• W4303984861 hasConcept C71924100 @default.
• W4303984861 hasConceptScore W4303984861C116675565 @default.
• W4303984861 hasConceptScore W4303984861C142724271 @default.
• W4303984861 hasConceptScore W4303984861C159047783 @default.
• W4303984861 hasConceptScore W4303984861C203014093 @default.
• W4303984861 hasConceptScore W4303984861C2522874641 @default.
• W4303984861 hasConceptScore W4303984861C2776409557 @default.
• W4303984861 hasConceptScore W4303984861C2777732132 @default.
• W4303984861 hasConceptScore W4303984861C2778137277 @default.
• W4303984861 hasConceptScore W4303984861C2779134260 @default.
• W4303984861 hasConceptScore W4303984861C2779820661 @default.
• W4303984861 hasConceptScore W4303984861C2780494569 @default.
• W4303984861 hasConceptScore W4303984861C2780727368 @default.
• W4303984861 hasConceptScore W4303984861C2781375147 @default.
• W4303984861 hasConceptScore W4303984861C3006700255 @default.
• W4303984861 hasConceptScore W4303984861C3007834351 @default.
• W4303984861 hasConceptScore W4303984861C3008058167 @default.
• W4303984861 hasConceptScore W4303984861C3019738921 @default.
• W4303984861 hasConceptScore W4303984861C524204448 @default.
• W4303984861 hasConceptScore W4303984861C71924100 @default.
• W4303984861 hasIssue "4" @default.
• W4303984861 hasLocation W43039848611 @default.
• W4303984861 hasLocation W43039848612 @default.
• W4303984861 hasOpenAccess W4303984861 @default.
• W4303984861 hasPrimaryLocation W43039848611 @default.
• W4303984861 hasRelatedWork W124127424 @default.
• W4303984861 hasRelatedWork W2005460711 @default.
• W4303984861 hasRelatedWork W2055680398 @default.
• W4303984861 hasRelatedWork W2090597652 @default.
• W4303984861 hasRelatedWork W2988256220 @default.
• W4303984861 hasRelatedWork W3178186717 @default.
• W4303984861 hasRelatedWork W3184386184 @default.
• W4303984861 hasRelatedWork W4210401150 @default.
• W4303984861 hasRelatedWork W4237880775 @default.
• W4303984861 hasRelatedWork W4287374796 @default.
• W4303984861 hasVolume "162" @default.
• W4303984861 isParatext "false" @default.
• W4303984861 isRetracted "false" @default.
• W4303984861 workType "article" @default.